During the first full year of President Trump’s term, healthcare insurance rates remained relatively steady, according to new data from the U.S. Census Bureau.

Apple has disrupted its share of technology-based markets before—from the home computer to the phone. The latest product from the global behemoth has set its sights on cardiology. The new Apple Watch Series 4 comes with an FDA-approved electrocardiogram (ECG) feature.

Several hospitals and healthcare organizations are now taking advantage of electronic data-sharing systems that provide real-time alerts about what’s happening within a facility, according to a report by Politico.

Hospital associations have launched a lawsuit that would prompt a court order to require drug companies to disclose the ceiling price for 340B drugs.

With individuals constantly on the go, it’s becoming more of a necessity to have digital access to important medical history information. Texas Health Resources is addressing the need by empowering patients access to their health records through the Apple Health app.

The Office of the National Coordinator for Health Information Technology (ONC) is being called on to develop a voluntary certification program to help improve the usability and safety of pediatric electronic health records (EHRs).

From taking swipes at specific drug companies on Twitter to promising to get pharmaceutical prices down “really, really substantially,” President Donald Trump has said a lot about lowering drug prices. However, many Americans aren’t buying into the rhetoric, according to a recent study.

In 2018, cancer deaths will rise to 9.6 million worldwide, according to new data from the International Agency for Research on Cancer.

The latest Apple Watch will feature an application that allows users to take their own electrocardiogram (ECG) reading.

Healthcare services company Cigna has launched a $250 million venture capital fund, Cigna Ventures. The fund will focus on transformative and innovative healthcare companies, including promising startups and growth-stage companies.